✦ LIBER ✦

Effectiveness of a single-day three-drug regimen of dexamethasone, palonosetron, and aprepitant for the prevention of acute and delayed nausea and vomiting caused by moderately emetogenic chemotherapy

✍ Scribed by Steven M. Grunberg; Matthew Dugan; Hyman Muss; Marie Wood; Susan Burdette-Radoux; Tracey Weisberg; Marisa Siebel

Publisher: Springer-Verlag
Year: 2008
Tongue: English
Weight: 148 KB
Volume: 17
Category: Article
ISSN: 0941-4355
DOI: 10.1007/s00520-008-0535-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Palonosetron (Aloxi®) and dexamethasone

Palonosetron (Aloxi®) and dexamethasone for the prevention of acute and delayed nausea and vomiting in patients receiving multiple-day chemotherapy

✍ Maurizio Musso; Renato Scalone; Vincenza Bonanno; Alessandra Crescimanno; Vita P 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 119 KB

Randomized, placebo-controlled, pilot st

Randomized, placebo-controlled, pilot study evaluating aprepitant single dose plus palonosetron and dexamethasone for the prevention of acute and delayed chemotherapy-induced nausea and vomiting

✍ Jon D. Herrington; Adam D. Jaskiewicz; Juhee Song 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB

## Abstract ## BACKGROUND. The combination of palonosetron and aprepitant is safe and effective in the prevention of chemotherapy‐induced emesis (CIE). The purpose of this pilot study was to ascertain the effectiveness of 1‐day versus 3‐day aprepitant in the prevention of acute and delayed nausea

Palonosetron in combination with 1-day v

Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial

✍ Luigi Celio; Sergio Frustaci; Angela Denaro; Angela Buonadonna; Antonio Ardizzoi 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 185 KB

Aprepitant for the prevention of chemoth

Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and tumor types: a randomized, double-blind study

✍ Bernardo L. Rapoport; Karin Jordan; Judith A. Boice; Arlene Taylor; Carole Brown 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 174 KB

A double-blind, crossover, randomized do

A double-blind, crossover, randomized dose-comparison trial of granisetron for the prevention of acute and delayed nausea and emesis in children receiving moderately emetogenic carboplatin-based chemotherapy

✍ Su G. Berrak; Nihal Ozdemir; Nadi Bakirci; Emine Turkkan; Cengiz Canpolat; Bahar 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 122 KB

Single-dose palonosetron for prevention

Single-dose palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with aggressive non-Hodgkin's lymphoma receiving moderately emetogenic chemotherapy containing steroids: results of a phase II study from the Gruppo Italiano per lo Studio dei Linfomi (GISL)

✍ Nicola Di Renzo; Antonella Montanini; Donato Mannina; Alessandra Dondi; Stefania 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 141 KB